184 related articles for article (PubMed ID: 35002301)
1. Cytochrome b561 Serves as a Potential Prognostic Biomarker and Target for Breast Cancer.
Yang X; Zhao Y; Shao Q; Jiang G
Int J Gen Med; 2021; 14():10447-10464. PubMed ID: 35002301
[TBL] [Abstract][Full Text] [Related]
2. Expression and clinical prognostic value of CYB561 in breast cancer.
Zhou X; Shen G; Ren D; Guo X; Han J; Guo Q; Zhao F; Wang M; Dong Q; Li Z; Zhao J
J Cancer Res Clin Oncol; 2022 Aug; 148(8):1879-1892. PubMed ID: 35486183
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome b561 regulates iron metabolism by activating the Akt/mTOR pathway to promote Breast Cancer Cells proliferation.
Zhou X; Guo X; Han J; Wang M; Liu Z; Ren D; Zhao J; Li Z
Exp Cell Res; 2023 Oct; 431(1):113760. PubMed ID: 37634562
[TBL] [Abstract][Full Text] [Related]
4. Human heart rate: heritability of resting and stress values in twin pairs, and influence of genetic variation in the adrenergic pathway at a microribonucleic acid (microrna) motif in the 3'-UTR of cytochrome b561 [corrected].
Zhang K; Deacon DC; Rao F; Schork AJ; Fung MM; Waalen J; Schork NJ; Nievergelt CM; Chi NC; O'Connor DT
J Am Coll Cardiol; 2014 Feb; 63(4):358-68. PubMed ID: 24140660
[TBL] [Abstract][Full Text] [Related]
5. Independent prognostic implications of
Ma C; Luo H; Cao J; Gao C; Fa X; Wang G
J Cancer; 2020; 11(23):7009-7022. PubMed ID: 33123291
[No Abstract] [Full Text] [Related]
6. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
7. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
8. Junctional Adhesion Molecule-Like Protein (JAML) Is Correlated with Prognosis and Immune Infiltrates in Lung Adenocarcinoma.
Fang L; Yu W; Yu G; Zhong F; Ye B
Med Sci Monit; 2022 Jan; 28():e933503. PubMed ID: 35034089
[TBL] [Abstract][Full Text] [Related]
9. Independent Prognostic Potential of GNPNAT1 in Lung Adenocarcinoma.
Zheng X; Li Y; Ma C; Zhang J; Zhang Y; Fu Z; Luo H
Biomed Res Int; 2020; 2020():8851437. PubMed ID: 33178836
[TBL] [Abstract][Full Text] [Related]
10. Increased Expression of INHBA Is Correlated With Poor Prognosis and High Immune Infiltrating Level in Breast Cancer.
Yu Z; Cheng L; Liu X; Zhang L; Cao H
Front Bioinform; 2022; 2():729902. PubMed ID: 36304286
[No Abstract] [Full Text] [Related]
11. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
[TBL] [Abstract][Full Text] [Related]
12. Using Weighted Gene Co-Expression Network Analysis to Identify Increased MND1 Expression as a Predictor of Poor Breast Cancer Survival.
Bao Z; Cheng J; Zhu J; Ji S; Gu K; Zhao Y; Yu S; Meng Y
Int J Gen Med; 2022; 15():4959-4974. PubMed ID: 35601002
[TBL] [Abstract][Full Text] [Related]
13. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
[TBL] [Abstract][Full Text] [Related]
14. UHRF1 Could Be a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma.
Li D; Chen B; Zeng Y; Wang H
Int J Gen Med; 2021; 14():6769-6776. PubMed ID: 34675635
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human Breast Cancer.
Li F; Zhang Y; Shi Y; Liu S
Crit Rev Eukaryot Gene Expr; 2021; 31(4):71-79. PubMed ID: 34587437
[TBL] [Abstract][Full Text] [Related]
16. UBASH3B Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Prostate Cancer.
Wang Z; Wang Y; Peng M; Yi L
Front Oncol; 2019; 9():1517. PubMed ID: 32010618
[No Abstract] [Full Text] [Related]
17. Identification of Alternative Splicing-Related Genes CYB561 and FOLH1 in the Tumor-Immune Microenvironment for Endometrial Cancer Based on TCGA Data Analysis.
Sun D; Zhang A; Gao B; Zou L; Huang H; Zhao X; Xu D
Front Genet; 2022; 13():770569. PubMed ID: 35836577
[No Abstract] [Full Text] [Related]
18. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
[No Abstract] [Full Text] [Related]
19. Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer.
Liu D; Liu S; Fang Y; Liu L; Hu K
Front Cell Dev Biol; 2021; 9():816230. PubMed ID: 35223869
[No Abstract] [Full Text] [Related]
20. Mutations in
van den Berg MP; Almomani R; Biaggioni I; van Faassen M; van der Harst P; Silljé HHW; Mateo Leach I; Hemmelder MH; Navis G; Luijckx GJ; de Brouwer APM; Venselaar H; Verbeek MM; van der Zwaag PA; Jongbloed JDH; van Tintelen JP; Wevers RA; Kema IP
Circ Res; 2018 Mar; 122(6):846-854. PubMed ID: 29343526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]